Benefit of pazopanib in advanced gastrointestinal stromal tumours: results from a phase II trial (SSG XXI, PAGIST)

por Eriksson, M., Reichardt, P., Joensuu, H., Krarup-Hansen, A., Hagberg, O., Hohenberger, P., Hagberg, H., Hansson, L., Foukakis, T., Pulkkanen, K., Bauer, S., Goplen, D., Blach Rossen, P., Sundby Hall, K.
Publicado 2021

Re-treatment with radium-223: first experience from an international, open-label, phase I/II study in patients with castration-resistant prostate cancer and bone metastases

por Sartor, O., Heinrich, D., Mariados, N., Méndez Vidal, M. J., Keizman, D., Thellenberg Karlsson, C., Peer, A., Procopio, G., Frank, S. J., Pulkkanen, K., Rosenbaum, E., Severi, S., Trigo Perez, J. M., Wagner, V., Li, R., Nordquist, L. T.
Publicado 2017